Education
About Us
Working with TipRanks
Follow Us
Lineage Cell Therapeutics, Inc. (LCTX)
:LCTX
LCTX Analyst Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
LCTX Stock 12 Month Forecast
Average Price Target
$4.00
▲(716.33% Upside)
| Highest Price Target$9.00 | Average Price Target$4.00 | Lowest Price Target$2.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
B.Riley Financial
Reiterated
03/14/25
Craig-Hallum
Reiterated
03/11/25
Maxim Group
Reiterated
03/11/25
H.C. Wainwright
Reiterated
03/10/25
D. Boral Capital
Reiterated
01/03/25
Robert W. Baird
$5
Buy
920.41%
Upside
Reiterated
11/14/24
Analysts Offer Insights on Healthcare Companies: Lineage Therap (NYSE MKT: LCTX), Veeva Systems (NYSE: VEEV) and Takeda Pharmaceutical Company (NYSE: TAK)
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
B.Riley Financial
Reiterated
03/14/25
Craig-Hallum
Reiterated
03/11/25
Maxim Group
Reiterated
03/11/25
H.C. Wainwright
Reiterated
03/10/25
D. Boral Capital
Reiterated
01/03/25
Robert W. Baird
$5
Buy
920.41%
Upside
Reiterated
11/14/24
Analysts Offer Insights on Healthcare Companies: Lineage Therap (NYSE MKT: LCTX), Veeva Systems (NYSE: VEEV) and Takeda Pharmaceutical Company (NYSE: TAK)
LCTX Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
9
6
8
5
8
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
9
6
8
5
8
Each month's total comprises the sum of three months' worth of ratings.
LCTX Financial Forecast
LCTX Stock Forecast FAQ
What is LCTX’s average 12-month price target, according to analysts?
Based on analyst ratings, Lineage Cell Therapeutics, Inc.’s 12-month average price target is $4.00.
What is LCTX’s upside potential, based on the analysts’ average price target?
Lineage Cell Therapeutics, Inc. has 716.33% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is LCTX a Buy, Sell or Hold?
Lineage Cell Therapeutics, Inc. has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
What is Lineage Cell Therapeutics, Inc.’s price target?
The average price target for Lineage Cell Therapeutics, Inc. is $4.00. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $9.00 ,the lowest forecast is $2.00. The average price target represents 716.33% Increase from the current price of $0.49.
The highest analyst price target is $9.00 ,the lowest forecast is $2.00. The average price target represents 716.33% Increase from the current price of $0.49.
What do analysts say about Lineage Cell Therapeutics, Inc.?
Lineage Cell Therapeutics, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
How can I buy shares of LCTX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.